Rapamycin conditioning of dendritic cells differentiated from human ES cells promotes a tolerogenic phenotype.
While human embryonic stem cells (hESCs) may one day facilitate the treatment of degenerative diseases requiring cell replacement therapy, the success of regenerative medicine is predicated on overcoming the rejection of replacement tissues. Given the role played by dendritic cells (DCs) in the esta...
主要な著者: | Silk, K, Leishman, A, Nishimoto, K, Reddy, A, Fairchild, P |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2012
|
類似資料
-
Directed differentiation of human induced pluripotent stem cells into dendritic cells displaying tolerogenic properties and resembling the CD141+ subset
著者:: Sachamitr, P, 等
出版事項: (2018) -
Differentiation of dendritic cells from human embryonic stem cells.
著者:: Silk, K, 等
出版事項: (2011) -
Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141+ Subset
著者:: Patty Sachamitr, 等
出版事項: (2018-01-01) -
Pharmacological manipulation of dendritic cells in the pursuit of transplantation tolerance.
著者:: Leishman, A, 等
出版事項: (2011) -
Tolerogenicity is not an absolute property of a dendritic cell.
著者:: Farquhar, C, 等
出版事項: (2010)